Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Verrica Pharmaceuticals 10%+ Owner Perceptive Advisors Reported Purchase Of 1,233,931 Shares @ Avg Price: Of $5.63/Share In Form 4 Filing On Tuesday

Author: Charles Gross | December 20, 2023 06:19am

Posted In: VRCA